Copyright
©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Oct 16, 2021; 9(29): 8647-8657
Published online Oct 16, 2021. doi: 10.12998/wjcc.v9.i29.8647
Published online Oct 16, 2021. doi: 10.12998/wjcc.v9.i29.8647
Healthcare practice strategies for integrating personalized medicine: Management of COVID-19
Wen-Yi Liu, Department of Health Policy and Management, Bloomberg School of Public Health, Johns Hopkins University, MD 21205, United States; Shanghai Bluecross Medical Science Institute, Shanghai 201100, Shanghai Province, China
Wen-Yi Liu, Ching-Wen Chien, Institute for Hospital Management, Tsing Hua University, Shenzhen Campus, Shenzhen 518055, Guangdong Province, China
Tao-Hsin Tung, Evidence-based Medicine Center, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai 317000, Zhejiang Province, China
Author contributions: Liu WY and Tung TH had full assessment for all of the data in the study and take responsibility for the integrity and accuracy of the data; Chien CW contributed to data interpretation and drafting the manuscript; all authors provided a critical review and approved the final manuscript.
Conflict-of-interest statement: The authors have no proprietary interest in any aspect of this review.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Tao-Hsin Tung, PhD, Director, Evidence-based Medicine Center, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, No. 150 Ximen Road, Linhai City, Linhai 317000, Zhejiang Province, China. ch2876@gmail.com
Received: February 17, 2021
Peer-review started: February 17, 2021
First decision: March 11, 2021
Revised: March 22, 2021
Accepted: August 18, 2021
Article in press: August 18, 2021
Published online: October 16, 2021
Peer-review started: February 17, 2021
First decision: March 11, 2021
Revised: March 22, 2021
Accepted: August 18, 2021
Article in press: August 18, 2021
Published online: October 16, 2021
Core Tip
Core Tip: For patients with coronavirus disease 2019 (COVID-19), providing the most effective treatment is a task of paramount importance in personalized medicine. The pandemic of COVID-19 is the opportunity and challenge to change toward a more personalized approach taking patients’ needs into consideration. Personalized medicine related research is ideally suited to dealing with infectious diseases; however, there has been relatively little research in this area.